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ABSTRACT
Objectives The purpose of this study was to examine 
the perspectives of primary care physicians in Texas 
around vaccine acceptance and potential patient barriers 
to vaccination. National surveys have shown fluctuating 
levels of acceptance for COVID- 19 vaccination, and 
primary care physicians could play a crucial role in 
increasing vaccine uptake.
Design This study employed a cross- sectional 
anonymous survey design to collect data using an online 
questionnaire. Participants were asked about vaccination 
practices and policies at their practice site, perceptions 
of patient and community acceptance and confidence in 
responding to patient vaccine concerns.
Setting From November 2020 to January 2021, family 
medicine physicians and paediatricians completed an 
online questionnaire on COVID- 19 vaccination that was 
distributed by professional associations.
Participants The survey was completed by 573 practising 
physicians, the majority of whom identified as family 
medicine physicians (71.0%) or paediatricians (25.7%), 
who are currently active in professional associations in 
Texas.
Results About three- fourths (74.0%) of participants 
reported that they would get the vaccine as soon as it 
became available. They estimated that slightly more than 
half (59.2%) of their patients would accept the vaccine, 
and 67.0% expected that the COVID- 19 vaccine would 
be accepted in their local community. The majority of 
participants (87.8%) reported always, almost always 
or usually endorsing vaccines, including high levels of 
intention to recommend COVID- 19 vaccination (81.5%). 
Participants felt most confident responding to patient 
concerns related to education about vaccine types, 
safety and necessity and reported least confidence in 
responding to personal or religious objections to COVID- 19 
vaccination.
Conclusions The majority of the physicians surveyed 
stated that they would receive the COVID- 19 vaccination 
when it was available to them and were confident in their 
ability to respond to patient concerns. With additional 
education, support and shifting COVID- 19 vaccinations 
into primary care settings, primary care physicians can 
use the trust they have built with their patients to address 
vaccine hesitancy and potentially increase acceptance 
and uptake.
INTRODUCTION
With emergency use authorisation for 
COVID- 19 vaccines approved in December 
2020, there is hope that the virus will become 
more controlled and a return to normalcy 
can be achieved. Essential to this goal is 
vaccinating enough of the population to 
achieve herd immunity, currently estimated 
at ≥80% of individuals in the USA.1 However, 
this concept of achieving heard immunity 
is changing in respect to COVID- 19 due to 
issues of vaccine hesitancy and uptake and 
may be unachievable, which is leading some 
to reorient towards reaching a reasonable 
level of ‘normalcy’.2 The number of Ameri-
cans willing to receive the vaccination fluctu-
ated throughout 2020, from as high as 72% 
in May to 60% in December.3 A recently 
published (February 2021) systematic review 
reported a lower acceptance rate (56.9%), 
indicating that 3 months of vaccine delivery 
did not result in higher potential uptake.4 
COVID- 19 vaccine uptake may especially be 
Key points
Question
 ► What are the perspectives of primary care physicians 
and pediatricians in Texas regarding COVID- 19 vac-
cine acceptance and patient barriers to vaccination?
Finding
 ► Vaccine acceptance was high among primary care 
physicians with the majority of the participants stat-
ing they would receive the COVID- 19 vaccine when 
available. Physicians were highly confident that they 
could address patient concerns regarding receipt of 
the vaccine. However, the vast majority of partici-
pants reported that they disagreed with dismissing 
a patient for refusing the COVID- 19 vaccine.
Meaning
 ► Primary care physicians are in a unique position to 
address COVID- 19 vaccine hesitancy and with addi-
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harder among minority groups (eg, African- Americans) 
who experience more health inequities.5
To reach normalcy in the USA, all of those who report 
that they will accept the vaccine will have to do so, and 
a significant number of those who are vaccine hesitant 
will have to be motivated to vaccinate. Vaccine confi-
dence and acceptance are largely predicated on trust in 
the safety and efficacy of the vaccine as well as in health-
care personnel, institutions and public and government 
officials who shape policies around vaccine dissemination 
and communication.6 Evidence- based and novel strate-
gies are needed to increase vaccine acceptance, especially 
in those communities with historical distrust of health-
care professionals or stringent antivaccination beliefs.7 
For example, Hildreth and Alcendor8 suggested a multi-
media approach using social media, flyers, pamphlets 
and radio commentaries in multiple languages in order 
to reach minority groups in the USA. They also propose 
the use of virtual town halls with community leaders in 
order to address questions that the general public might 
have about the COVID- 19 vaccine.8
A sizeable body of literature demonstrates that 
healthcare clinician recommendation is one of the 
most important factors in decreasing vaccine hesitancy 
and improving vaccine confidence, thereby improving 
vaccine uptake.9 10 This finding is borne out in two recent 
national survey of US adult acceptance of a COVID- 19 
vaccine.7 11 In the study by Head and colleagues, almost a 
quarter of respondents (n=739) reported that they would 
be more likely to receive the vaccine if their healthcare 
provider recommended it.11 In a national study of 672 
participants, the majority of respondents identified 
“their own physician” as the most reliable source of infor-
mation about COVID- 19.7 It is important to note that 
vaccine hesitancy in parents when concerning childhood 
vaccinations has been linked being uncertain on whether 
they trust their paediatrician and to thoughts that their 
physician has not provided adequate information on 
vaccines.12 13
Undoubtedly, many patients will take the vaccine 
without any need for education, information or encour-
agement, but the novelty of the COVID- 19 virus and 
vaccine technologies, as well as the speed of development, 
have the potential to introduce new barriers to vaccina-
tion. Furthermore, given that none of the initial vaccine 
trials enrolled children or pregnant women, and these 
groups tend to have higher incidences of vaccine hesitancy 
than the general population,14 15 primary care physicians 
(PCPs) will be crucial in providing accurate information 
and addressing patient concerns as the US approaches 
future phases of vaccine candidacy.16 However, while a 
few studies have gauged healthcare clinician acceptance 
of COVID- 19 vaccines in general,17 18 no studies to date 
have explored the perspectives of PCPs on providing the 
vaccine to patients, anticipated acceptance by their patient 
population or the sources of hesitancy and concern that 
they are preparing to address. It is important to note, 
unless indicated, the authors are including paediatricians 
as PCPs based on definitions provided by the American 
Academy of Family Physicians.16
In order to gain insight into these factors, we surveyed 
paediatricians and family medicine physicians in Texas. 
Our objective was to understand PCPs’ experiences with 
COVID- 19, their knowledge and willingness to receive the 
COVID- 19 vaccines, their perspectives on their patients’ 
hesitancy to receive the vaccine and their willingness 




This cross- sectional study consisted of an online question-
naire that was disseminated to a combined total of 8364 
family medicine physicians and paediatricians across 
Texas. Two professional associations, the Texas Academy 
of Family Physicians19 and the Texas Pediatric Society,20 
were contacted and agreed to distribute the questionnaire 
to all active members via email from 20 November 2020 
to 31 January 2021. It is important to note, during this 
time, two mRNA vaccines for COVID- 19 were approved 
for emergency use authorisation for adults.21 The profes-
sional associations sent an email containing the study 
description, contact information and a link to the ques-
tionnaire. Data were collected and stored using Research 
Electronic Data Capture, a web- based software used to aid 
research studies in securing and storing data.22 23 Partici-
pants were not incentivised and were given the option to 
skip questions that they did not want to answer. Responses 
to the questionnaire were anonymous.
Inclusion and exclusion criteria
The only inclusion criteria was that all participants had 
to be active members of one of the two professional 
associations.
Measures
The questionnaire used in this study was developed by 
the investigators to assess the perspectives of the physi-
cians regarding COVID- 19 vaccination. In addition 
to background and demographic questions, we asked 
participants about their medical training, practice char-
acteristics, and patient population. Participants were also 
asked about vaccination practices at their site, including 
the age ranges that they vaccinate, vaccine endorsement 
frequency and dismissal policies (ie, polices related to 
discontinuing medical care of a patient) related to patient 
vaccine hesitancy or refusal. To assess vaccine intentions, 
participants (ie, physicians) were asked if and when they 
would accept vaccination for COVID- 19. They were also 
asked to identify potential types of COVID- 19 vaccines 
(eg, viral vector), estimate acceptance of COVID- 19 
vaccines by their patients and in their community. Finally, 
participants were asked to rate their confidence in 
responding to concerns related to delaying or refusing 
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a psychometric method used to assess the attitudes and 
motivations of individuals.24 Given that all questions were 
developed by the investigators specifically for this project 
and the recent onset of COVID- 19, the questionnaire was 
not validated nor piloted prior to this study.
Descriptive statistics
Responses to questions were summarised using descrip-
tive statistics using SPSS V.26.25 Percentages and means 
with SDs (when applicable) were reported for each 
response.
RESULTS
Of the 676 individuals who opened the questionnaire, 103 
did not complete any questions and were excluded from 
the data analysis. In total, 573 participants were included 
in the final sample.
Demographics
A description of participants (n=573) and their practice 
setting are presented in table 1. About 3/4 (71.0%) of 
the sample were family medicine physicians. Slightly 
more than half of the sample was white (59.3%), and 
about 10% were of Hispanic ethnicity. The most common 
religion among participants was Christianity of some type 
(55%). The type, size and location of clinical practice 
settings were quite diverse.
Experiences with vaccines in patients
Participants’ experiences with patient vaccination are 
presented in table 2. Depending on the patient age 
group, from about 1/2 to 2/3 of participants reported 
that they provide vaccines to their patients in their prac-
tice. The majority of participants (87.8%) reported that 
they usually, always, or almost always endorse vaccines 
with their patients.
COVID-19 vaccination expectations
Data on COVID- 19 vaccination expectations are presented 
in table 3. About 2/3 (65.6%) of participants were able to 
correctly identify the type of vaccine expected to be out 
soon as an RNA vaccine. Participants anticipated that over 
half (59.2%) of patients in their practice would accept 
the COVID- 19 vaccine, and about 2/3 (67.0%) thought 
that the vaccine would be accepted in their local commu-
nity. Three- fourths (74.0%) of participants indicated that 
they would get the vaccine as soon as it was available with 
only about 6% reporting that they would not get or were 
unsure if they would get the vaccine.
COVID-19 vaccine and patient dismissal practices
As noted in table 4, only a small number of participants 
(8.9%) indicated that they thought that physicians should 
dismiss parents or patients who refuse the COVID- 19 
vaccine. The most commonly cited potential reasons 
for dismissal were concern for either the safety of other 
patients (47.6%) or clinical staff (40.8%). In terms of 
rating their own confidence to respond to patients and 
Table 1 Description of sample and practice (n=573)
Variable N or mean % or SD
Specialty
  Family medicine 407 71.0
  Paediatrics 147 25.7
  Other* 18 3.1
  Missing 1 0.2
Age (n=425)† 50.88 11.8
Race
  White 340 59.3
  Asian 57 9.9
  Black/African- American 18 3.1
  Other 17 3.0
  Missing 141 24.6
Hispanic ethnicity 65 11.3
Religion
  Christianity Protestant 184 32.1
  Christianity Catholic 88 15.4
  No religion 50 8.7
  Christianity other 43 7.5
  Prefer not to answer 23 4.0
  Judaism 13 2.3
  Islam 8 1.4
  Hinduism 7 1.2
  Buddhism 5 0.90
  Other 4 0.7
  Missing 143 25.0
Main clinical practice setting
  Independent small solo or group 
practice (<10 physicians)
201 35.1
  Employed by health system 131 22.9
  Independent large group 
practice (>10 physicians)
76 13.3
  Academic teaching clinic 62 10.8
  Other/NA 42 7.3
  Federally qualified health centre 
or community health centre
35 6.1
  Urgent care 17 3.0
  Veterans Affairs or other military 
services
4 0.7
  Health department 1 0.2
Number of physicians in practice where employed
  Solo practice 129 22.5
  2–3 129 22.5
  4–10 188 32.8
  >10 122 21.3
  Missing 5 0.9





















ealth: first published as 10.1136/fm






4 Day P, et al. Fam Med Com Health 2021;9:e001228. doi:10.1136/fmch-2021-001228
Open access 
parents who want to delay or refuse the vaccine, highest 
average confidence ratings were for issues related to 
patient education: belief that the vaccine would cause 
illness (8.12), not knowing enough about the vaccine 
(8.08) or thinking that it was not needed or necessary 
(7.92). Participants reported lowest average ratings of 
confidence for responding to parents or patients for 
whom the vaccine was not consistent with their religious 
or personal beliefs (5.85).
DISCUSSION
Based on our results, we expect that the majority of family 
medicine physicians and paediatricians in Texas will 
accept vaccination for COVID- 19, and most of those will 
do so as soon as possible. This finding aligns with other 
studies that show high acceptance of the vaccine among 
healthcare workers,26 27 but this study is unique as it focuses 
specifically on the attitudes of PCPs in the USA. A similar 
study conducted with general practitioners (n=1623) 
and primary care nurses (n=1055) in Canada, France 
and Belgium from October to November 2020 found 
high levels of COVID- 19 vaccine acceptance (74.98%).28 
Similarly high levels of participants (79.27%) reported 
that they would recommend COVID- 19 vaccines to their 
patients. The high level of reported acceptance, coupled 
with frequent vaccine endorsement, including majority 
intention to endorse COVID- 19 vaccination, is crucial as 
physician vaccine attitudes and recommendation are vital 
to patient uptake.10 29 Participants estimated patient and 
community acceptance at rates similar to those reported 
in national surveys,3 7 30 yet still not high enough to reach 
herd immunity or a level of normality.2
At the time of questionnaire dissemination, only the 
mRNA vaccines (Pfizer- BioNTech and Moderna) were 
candidates for emergency use authorisation.21 While the 
majority of participants correctly identified these vaccine 
types, the novelty of the technology warrants increased 
physician education show that they can effectively answer 
patient questions, discuss how the vaccines work and 
address relevant concerns about safety and efficacy.31 
Informed approaches will be especially important as 
new variants arise, more vaccine types become available 
and more individuals become eligible for vaccination. In 
terms of dismissal policies, prior research has shown that 
Variable N or mean % or SD
  Suburban 253 44.2
  Urban 218 38.1
  Rural 90 15.7
  Other/unknown/missing 12 2.1
Most common type of payor for practice
  Private insurance (includes 
Tricare)
291 50.8
  Medicare 95 16.6
  Medicaid/CHIP 93 16.2
  Uninsured/charity/self- pay 41 7.2
  Other/don’t know/not 
applicable/missing
38 6.6
Number of patients seen per week in practice
  Less than 25 53 9.3
  25–49 108 18.8
  50–100 325 56.7
  Other/NA/missing 87 15.2
*The individuals who identified as ‘other’ specialty were members 
of the Texas Academy of Family Physicians and the Texas 
Paediatric Society but did not identify primarily as family medicine 
or paediatric physicians.
†Mean and SD.
Table 1 Continued Table 2 Experiences with vaccines in practice
Variable N %
Location where majority of your patients receive their 
vaccines
  Age group: ages 0–2 years
   In own clinic 305 53.2
   Health department 20 3.5
   From other physician 31 5.4
   Do not know/do not treat age group/
missing
217 37.9
  Age group: ages 2–18 years
   In own clinic 370 64.6
   Health department 25 4.4
   From other physician 28 4.9
   Do not know/do not treat age group/
missing
150 26.2
  Age group: ages 18–65 years
   In own clinic 347 60.6
   Health department 18 3.1
   From other physician 26 4.5
   Do not know/do not treat age group/
missing
182 31.8
  Age group: ages: over 65 years
   In own clinic 302 52.7
   Health department 17 3.0
   From other physician 25 4.4
   Do not know/do not treat age group/
missing
229 40.0
Frequency of endorsing vaccines with patients
  Always or almost always 488 85.2
  Usually 15 2.6
  Sometimes 1 0.2
  Rarely or never 2 0.4
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most physicians do not endorse dismissing patients who 
refuse vaccines, though the practice has grown over the 
last decade and is more prominent among paediatricians 
than family medicine physicians.32 We report similarly 
low endorsement of dismissal, though our findings are 
consistent with the few studies that show that dismissal is 
used to promote clinical safety and reduce disease risk for 
other patients.33 While COVID- 19 is highly transmissible, 
with a rate of reproduction (R0) ranging from 1.9 to 6.5,
34 
and the effects are potentially life threatening, our study 
suggests that physicians may feel a duty to provide care to 
their patients and a willingness to assume risks associated 
with unvaccinated patients.
Our study identified physician self- reported confidence 
at high levels to respond to specific patient concerns 
about COVID- 19 vaccination. Participants indicated that 
they felt most confident in situations related to educating 
patients where factual information might be used to 
address patient concerns. Specifically, most participants 
felt confident providing general information about the 
vaccines and discussing the safety and necessity of vacci-
nation. PCPs and other healthcare professionals have 
been identified as trustworthy sources of COVID- 19 infor-
mation7 and may be the best situated group to counter 
misinformation that could dissuade patients from 
accepting vaccination. A 2021 study of 5 years of Medi-
care data (2012–2017) found that PCPs provide the most 
vaccines in the USA,35 which supports that they are both 
experienced and well equipped to provide COVID- 19 
vaccinations, immunisation counselling and ongoing 
clinical guidance to patients. However, others have noted 
that COVID- 19 vaccinations in the USA have mainly been 
occurring outside of primary care settings, and thus, to 
encourage the vaccine hesitant to receive the COVID- 19 
vaccine, vaccination efforts may need to be shifted to 
Table 3 COVID- 19 vaccine expectations
Variables N or mean % or SD
Correctly identified type of vaccine 
expected to be out soon (RNA)
376 65.6
Percentage of patients anticipated to 
accept the COVID- 19 vaccine in your 
practice*
59.15 19.1
Believe that the COVID- 19 vaccine 
will be accepted in your local 
community
  Yes 384 67.0
  No 45 7.9
  Do not know 74 12.9
  Missing 70 12.2
When you will get the COVID- 19 
vaccine
  As soon as it is available 424 74.0
  After it has been used for a few 
months
33 5.8
  More than 6 months after 
introduced
13 2.3
  Never 5 0.9
  Not sure if I will get the COVID- 19 
vaccine
29 5.1
  Missing 69 12.0
Will endorse the COVID- 19 vaccine to 
your patients
  Yes 467 81.5
  No 5 0.9
  Do not know 32 5.6
  Missing 69 12.0
*Mean and SD.
Table 4 COVID- 19 vaccine and patient dismissal practices
Variables N or mean % or SD
Physicians should dismiss parents or patients who refuse 
COVID- 19 vaccination
  Strongly agree 17 3.0
  Somewhat agree 34 5.9
  Neither agree nor disagree 81 14.1
  Somewhat disagree 129 22.5
  Strongly disagree 210 36.7
  Missing 102 17.8
What are potential reasons for dismissing families or patients 
who refuse COVID- 19 vaccine?
  Concern for safety of other patients 273 47.6
  Concern for the safety of clinical 
staff
234 40.8
  Lack of shared goals for care 169 29.50
  Lack of trust between patient and 
doctor
157 27.4
  Other 54 9.4
  Fear of litigation 41 7.2
  Negative effect on quality metrics 40 7.0
How confident are you in your ability to respond to patients/
parents who want to delay or refuse the COVID- 19 vaccine 
because*
  They think the vaccine will cause 
illness
8.12 2.0
  They do not know enough about it 8.08 1.9
  It is not needed or necessary 7.92 2.0
  They heard or read bad things about 
the vaccine in the news
7.52 2.2
  They do not trust healthcare 
personnel
7.41 2.4
  They have concerns about lasting 
health problems due to the vaccine
7.09 2.3
  It is not consistent with their 
religious or personal beliefs
5.85 2.9
*Mean and SD. For these questions, physicians rated their 
confidence on a scale of 1–10 with one being the least confident 
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primary care in order to take advantage of the trust the 
PCPs have built with their patients.36
Participants reported that they felt the least confident in 
responding to patients’ personal or religious objections. 
In this study, the majority of participants self- identified as 
having some type of religious affiliation, most commonly 
a Christian denomination. We did not collect data on 
the religious preferences or affiliations of participants’ 
patients, but according to the Pew Research Center, 77% 
of adult Texans identify as Christian.37 Thus, while there is 
ongoing debate within the medical and ethical literature 
about the role of physicians’ spirituality in the practice of 
medicine,38 it is possible some physicians may choose to 
have discussions about religion and its impact on vaccine 
decisions with their patients. However, it is unknown 
whether comfort level in having such discussions varies by 
the religion of the physician and patient.
PCPs are ideally situated to deliver guidance and 
messaging on COVID- 19 vaccination. It is important to 
note that in general PCPs are given little or no training 
on how to manage discussion of controversial topics with 
their patients.18 Therefore, providing training on how 
to address COVID- 19 vaccine hesitancy or controversial 
topics in general may be beneficial to increase vaccina-
tion rates. To this end, PCPs may benefit from assistance 
from professional associations, medical institutions and 
local governments who provide factual information that 
they can provide to patients who are considering whether 
to accept the vaccine. Possible reasons for refusal will 
likely be diverse and vary by region of the USA, which 
may necessitate tailored messaging and thoughtful 
discussions. PCPs should emphasise the benefits of vacci-
nation, including the ability to travel, visit loved ones 
in nursing homes and achieve a return to normalcy. 
Messaging should be adapted to physician comfort level, 
local contexts and patient factors in order to successfully 
impact vaccine uptake.
Limitations
While this study provides timely data on physician’s expec-
tations for the COVID- 19 vaccine, our sample was only 
conducted in one state and with just family medicine physi-
cians and paediatricians, and thus the findings may not be 
generalisable to other physicians practising in other states. 
It is also possible that there are factors not addressed in 
this questionnaire that may impact vaccination uptake. 
The response rate for this questionnaire is also a significant 
limitation that could potentially hamper the generalisability 
of our findings, though we do report data from a variety of 
practice types and settings. Due to the low response rate, 
it is possible that response biases (ie, recall bias and social 
desirability bias) may have skewed the results of our sample 
and may not represent the population of PCPs in Texas. 
Furthermore, the rate of vaccine acceptance responses and 
endorsements could also be skewed by physicians’ desire to 
report socially and scientifically accepted positions on vacci-
nations. Finally, given the method of sampling and the lack 
of data on actual vaccination behaviours (eg, COVID- 19 
vaccination status of participants or patients) follow- up 
studies are warranted to determine the vaccination uptake 
by PCPs and their patients in Texas. Nevertheless, the novelty 
of our findings and the role that they could play in future 
studies or in the development of messaging for patients 
should be balanced against the low rate of questionnaire 
return. The questionnaire and the questions contained 
within it were developed specifically this study and were 
created to address issues that were important to the study 
investigators. Thus, the questionnaire is not validated and 
may not be generalisable to other study populations.
Implications
These data can be used to assist in the development of 
targeted messaging aimed at improving vaccine uptake and 
advancing the public health goal of minimising disease and 
achieving a return to normality. With additional education, 
support and shifting COVID- 19 vaccinations into primary 
care setting, PCPs can use the trust they have built with 
their patients to address vaccine hesitancy in their patients. 
Governments, institutions and medical associations should 
provide PCPs with the resources needed to respond to 
patient vaccine hesitancy and to increase vaccine confi-
dence and uptake of COVID- 19 vaccination.
CONCLUSIONS
We surveyed PCPs in the state of Texas to assess their accep-
tance of COVID- 19 vaccination and their perceptions of 
patient and community acceptance. The vast majority of the 
PCPs surveyed stated that they would receive the COVID- 19 
vaccination when it was available to them and were able to 
correctly identify the type of vaccines available. We found 
that PCP confidence to respond to patient concerns about 
COVID- 19 vaccines was fairly high for all of the patient 
concerns identified. Finally, the PCPs in our study stated 
they would not dismiss a patient despite not receiving the 
COVID- 19 vaccine, which suggests a commitment to the 
needs of all patients, including those who choose not to get 
the vaccine.
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